These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19519731)

  • 21. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome.
    Lee SJ; Lee JJ; Kim SY; Kim SD
    Korean J Ophthalmol; 2009 Jun; 23(2):132-4. PubMed ID: 19568367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.
    Sagong M; Kim J; Chang W
    Korean J Ophthalmol; 2009 Sep; 23(3):215-8. PubMed ID: 19794952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab for choroidal neovascularization secondary to inflammation.
    Wolf A; Thurau S; Kook D; Hoeing A; Priglinger S; Kampik A; Haritoglou C
    Acta Ophthalmol; 2010 Nov; 88(7):e295-6. PubMed ID: 19860782
    [No Abstract]   [Full Text] [Related]  

  • 25. Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab.
    Kubota T; Aoki R; Harada Y; Tou N; Kohno Y; Tawara A; Satoh H; Shimajiri S
    Br J Ophthalmol; 2009 Apr; 93(4):557-8. PubMed ID: 19321485
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical and surgical treatment of neovascular glaucoma.
    Olmos LC; Lee RK
    Int Ophthalmol Clin; 2011; 51(3):27-36. PubMed ID: 21633236
    [No Abstract]   [Full Text] [Related]  

  • 27. Intraocular avastin (bevacizumab) for neovascularisation of the iris and neovascular glaucoma.
    Cheng JY; Wong DW; Ang CL
    Ann Acad Med Singap; 2008 Jan; 37(1):72-4. PubMed ID: 18265902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO; Albert MA; Mays A; Vail R
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
    Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
    J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
    Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
    Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
    Silva Paula J; Jorge R; Alves Costa R; Rodrigues Mde L; Scott IU
    Acta Ophthalmol Scand; 2006 Aug; 84(4):556-7. PubMed ID: 16879583
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients.
    Cornish KS; Ramamurthi S; Saidkasimova S; Ramaesh K
    Eye (Lond); 2009 Apr; 23(4):979-81. PubMed ID: 18451875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.
    Patel CK; Walker NJ; Kam JK
    Br J Ophthalmol; 2010 Aug; 94(8):1107-9. PubMed ID: 20558426
    [No Abstract]   [Full Text] [Related]  

  • 34. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma.
    Wolf A; von Jagow B; Ulbig M; Haritoglou C
    Ophthalmologica; 2011; 226(2):51-6. PubMed ID: 21546781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery].
    Lüke J; Lüke M; Grisanti S
    Ophthalmologe; 2009 May; 106(5):407-12. PubMed ID: 19418055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
    Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
    Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy.
    Falavarjani KG; Modarres M; Nazari H
    Eye (Lond); 2010 Apr; 24(4):717-9. PubMed ID: 19407842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of choroidal metastasis secondary to breast carcinoma with adjuvant intravitreal injection of bevacizumab.
    Yao HY; Horng CT; Chen JT; Tsai ML
    Acta Ophthalmol; 2010 Nov; 88(7):e282-3. PubMed ID: 19845564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.